News

VIPC’s Robert Stolle Announces Plans to Step Down From His Role as President and CEO

As CEO, Bob Stolle led Virginia’s consolidation of several innovation and entrepreneurship programs into the newly established VIPC. This consolidation expanded and coordinated programs that provide support for Virginia’s entrepreneurs, tech startups, research commercialization, regional ecosystems, and new industry sectors such as Advanced Air Mobility and Smart Communities.

“Having the privilege of leading VIPC over the last three years has been the most rewarding experience of my professional career” Stolle said. “VIPC has a staff of exceptionally talented and experienced professionals. I’m very proud of where we are as a team, but I believe this is a good time to pass the baton to the next generation of leadership for innovation in Virginia”.

“The Commonwealth has benefited greatly and will continue to benefit for years to come from Bob’s many years of investing his considerable talents, time, and exemplary service,” said Caren Merrick, Secretary of Commerce and Trade and Vice Chair of VIPC.

“Under Bob’s leadership, VIPC has forged a series of integrated programs to help entrepreneurs bring their technologies to commercialization, whether the technology originates in one of Virginia’s academic institutions or in the private sector. As an entrepreneur myself, I know that these programs make a real difference in the success of our emerging and growing tech enterprise,” said Barbara D. Boyan, PhD, Chair of the VIPC Board of Directors and Executive Director of the Institute for Engineering and Medicine at Virginia Commonwealth University.

Joseph Benevento, Virginia Deputy Secretary of Commerce & Trade, will assume the role of Interim CEO beginning in September, while the VIPC Board recruits a permanent CEO. Bob Stolle will stay on in an advisory role to assist in the transition until at least the end of October.

“I’m very grateful to the VIPC Board of Directors and to the Youngkin Administration for their trust, support, and for the opportunity to serve the Commonwealth of Virginia” Stolle said.

Learn more here.

Recent News

09/30/2026

Activation Capital Recognizes President Michael Rao’s 17 Years of Leadership as Authority Board Chair, Names Paul Nolde as New Chair

Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, today announced the election of Paul Nolde as chair of the Authority Board, succeeding Virginia Commonwealth University President Michael Rao, Ph.D., who has served as chair since 2009. Rao will remain an active member of the board, continuing his longstanding support of Activation …

09/22/2026

ATCC to Lead Lifecycle Management of Military Medical Countermeasures Under 10-Year Department of War Contract

ATCC has been awarded a 10-year Department of War (DOW) contract to coordinate lifecycle management of medical countermeasures (MCMs) developed to protect U.S. military personnel from chemical and biological threats. Under this contract, ATCC supports the mission of the Rapid Access to Products in Development (RAPID) program to enable MCM preparedness against chemical and biological …

09/22/2026

Quoin Pharmaceuticals Announces FDA Fast Track Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to QRX003 for the treatment of Peeling Skin Syndrome (PSS). QRX003 is an investigational topical serine protease inhibitor lotion. …